Von Willebrand Disease

Practical Hemostasis and Thrombosis: Second Edition

Volumn , Issue , 2010, Pages 73-87

  Castaman, Giancarlo ^a   Tosetto, Alberto ^a   Rodeghiero, Francesco ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Desmopressin; Factor VIII von willebrand factor concentrates; Inherited bleeding disorders; Von willebrand disease gene mutation; Von willebrand factor

Indexed keywords

EID: 84885800067     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444306286.ch8     Document Type: Chapter

References (42)

1. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987;69:454-9.
2. Mancuso DJ, Tuley EA, Westfield LA, et al. Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction. Biochemistry 1991; 30:253-69.
3. Wagner DD. Cell biology of von Willebrand factor. Annu Rev Cell Biol 1990;6:217-46.
4. Furlan M, Robles R, Lammle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996;87:4223-34.
5. Ruggeri ZM. Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation. Clin Haematol 2001;14:257-79.
6. Vlot AJ, Koppelman SJ, Bouma BN, Sixma JJ. Factor VIII and von Willebrand Factor. Thromb Haemost 1998;79:456-65.
7. Sadler JE, Budde U, Eikenboom JC, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006;4:2103-14.
8. Lyons SE, Bruck ME, Bowie EJW, Ginsburg D. Impaired cellular transport produced by a subset of type IIA von Willebrand disease mutations. J Biol Chem 1992;267:4424-30.
9. Castaman G, Federici AB, Rodeghiero F, Mannucci PM. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica 2003;88:94-108.
10. Baronciani L, Federici AB, Castaman G, Punzo M, Mannucci PM. Prevalence of type 2b 'Malmö/New York' von Willebrand disease in Italy: the role of von Willebrand factor gene conversion. J Thromb Haemost 2008;6:887-90.
11. Rodeghiero F, Castaman G. Congenital von Willebrand disease type I: definition, phenotypes, clinical and laboratory assessment. Best Pract Res Clin Haematol 2001;14:321-35.
12. Castaman G, Eikenboom JCJ, Missiaglia E, Rodeghiero F. Autosomal dominant type 1 von Willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect. Br J Haematol 2000;108:876-9.
13. Eikenboom JC, Matsushita T, Reitsma PH, et al. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor. Blood 1996;88:2433-41.
14. Mannucci PM, Lombardi R, Castaman G, et al. von Willebrand disease "Vicenza" with larger-than-normal (supranormal) von Willebrand factor multimers. Blood 1988;71:65-70.
15. Schneppenheim R, Federici AB, Budde U, et al. Von Willebrand disease type 2 M "Vicenza" in Italian and German patients: identification of the first candidate mutation (G3864A; R1205H) in 8 families. Thromb Haemost 2000;83:136-40.
16. Casonato A, Pontara E, Sartorello F, et al. Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. Blood 2002;99:180-4.
17. Eikenboom JCJ, Reitsma PH, Peerlinck KMJ, et al. Recessive inheritance of von Willebrand's disease type I. Lancet 1993;341:982-6.
18. Goodeve A, Eikenboom J, Castaman G, et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and ClinicalMarkers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood 2007;109:112-21.
19. James PD, Notley C, Hegadorn C, et al. The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study. Blood 2007;109:145-54.
20. Eikenboom J, Van Marion V, Putter H, et al. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD. J Thromb Haemost 2006;4:774-82.
21. James PD, Paterson AD, Notley C, et al. Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study. J Thromb Haemost 2006;4:783-92.
22. Cumming A, Grundy P, Keeney S, et al. An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease. Thromb Haemost 2006;96:630-41.
23. Mohlke KL, Ginsburg D. von Willebrand disease and quantitative variation in von Willebrand factor. J Lab Clin Med 1997;130:252-61.
24. Eikenboom JCJ. Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology. Clin Haematol 2001;14:365-79.
25. Rodeghiero F, Castaman G. von Willebrand disease: epidemiology. In: Lee CA, Berntorp EE, Hoots WK, eds. Textbook of Hemophilia. Oxford: Blackwell, 2005;265-71.
26. Castaman G, Eikenboom JCJ, Bertina R, Rodeghiero F. Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiologic investigation. Thromb Haemostas 1999;82:1065-70.
27. Budde U, Schneppenheim R, Eikenboom J, et al. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD). J Thromb Haemost 2008;6:762-71.
28. Castaman G, Rodeghiero F, Tosetto A, et al. Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an International, multicenter study. J Thromb Haemost 2006;4:2164-9.
29. Rodeghiero F, Castaman G, Tosetto A, et al. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost 2005;3:2619-26.
30. Tosetto A, Rodeghiero F, Castaman G, et al. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD). J Thromb Haemost 2007;5:715-21.
31. Castaman G, Lethagen S, Federici AB, et al. Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD. Blood 2008;111:3531-9.
32. Haberichter SL, Castaman G, Budde U, et al. Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD). Blood 2008;111:4979-85.
33. Rodeghiero F, Castaman G. Treatment of von Willebrand disease. Semin Hematol 2005;42:29-35.
34. Castaman G, Lattuada A, Mannucci PM, et al. Factor VIII:C increases after desmopressin in a subgroup of patients with autosomal recessive vonWillebrand disease. Br J Haematol 1995;89:147-51.
35. Mannucci PM, Tenconi PM, Castaman G, Rodeghiero F. Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: a cross-over randomized trial. Blood 1992;79: 3130-7.
36. Lethagen S, Kyrle PA, Castaman G, et al. von Willebrand factor/factor VIII concentrate (Haemate P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery. J Thromb Haemost 2007;5:1420-30.
37. Berntorp E, Petrini P. Long-term prophylaxis in von Willebrand disease. Blood Coagul Fibrinolysis 2005;16:S23-6.
38. Federici AB, Castaman G, Franchini M, et al. Clinical use of Haemate P in inherited von Willebrand disease: a cohort study on 100 Italian patients. Haematologica 2007;92:944-51.
39. Kouides PA. Females with von Willebrand disease: 72 years as the silent majority. Haemophilia 1998;4:665-76.
40. Castaman G, Eikenboom JCJ, Contri A, Rodeghiero F. Pregnancy in women with type 1 von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F. Thromb Haemostas 2000;84: 351-2.
41. Castaman G, Federici AB, Bernardi M, Moroni B, Bertoncello K, Rodeghiero F. Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect. J Thromb Haemost 2006;4:357-60.
42. Castaman G, Bertoncello K, Bernardi M, Rodeghiero F. Pregnancy and delivery in patients with homozygous or heterozygous R854Q type 2N von Willebrand disease. J Thromb Haemost 2005;3:391-2.